Burjeel puts 4 UAE day surgery centres into new platform for Gulf expansion

Burjeel Holdings has created a dedicated day surgery platform for its four UAE centres, appointing Arun Lobo as chief executive, Pawan Sharma as chief financial officer and Dr. Omer Baldo as chief medical officer on 1 October 2026.

The change matters first to CEOs and CFOs in Dubai, where clinics licensed by the Dubai Health Authority (DHA) face a sharper competitive test if hospital groups move more elective work into lower-acuity settings. It also matters to operators in Abu Dhabi and Al Ain, where Burjeel’s current centres sit under the Department of Health Abu Dhabi (DOH Abu Dhabi), and to northern emirates providers regulated by the Ministry of Health and Prevention (MOHAP) if the model spreads through payer networks.

What Burjeel changed

Burjeel said the platform brings together Burjeel Day Surgery Center, Al Reem Island, Burjeel Day Surgery Center, Shahama, Burjeel Day Surgery Center, Al Dhafra and Burjeel Day Surgery Center, Al Dhahir, Al Ain. The company said the centres will operate under common clinical, operational and financial oversight, with accountability for quality, patient experience, growth and profitability.

It has its own operating dynamics, capital requirements, and growth potential.
Dr. Shamsheer Vayalil, chairman and CEO, Burjeel Holdings

Burjeel’s announcement said its mid-term plan includes four additional UAE centres and two centres in Saudi Arabia. Its Saudi Burjeel One day surgery centres require about AED 140 million of capex each and are expected to generate more than AED 200 million in annual revenue at maturity, with a mid-20s EBITDA margin.

The company has also told investors that, between 2026 and 2028, it plans to add two hospitals in Dubai, four day surgery centres, six medical centres and two Trust Fertility Clinic branches in Al Ain and Dubai, according to its strategy update.

Why clinics and insurers should care

For Dubai clinic owners, the signal is mainly competitive. A day surgery platform can pull suitable elective cases out of hospital theatres and into dedicated centres. That affects referral patterns for orthopaedics, urology, gynaecology, ophthalmology and gastroenterology, depending on payer approvals and each facility’s licensed scope. DHA-licensed providers should compare their day-case authorisations, theatre utilisation and denial rates against peers before Burjeel’s Dubai pipeline reaches the market.

Burjeel did not publish UAE procedure prices, and operators should avoid using public cash quotes as reimbursement benchmarks. CFOs should instead review paid-claims data by service code through DHA eClaimLink in Dubai and DOH Abu Dhabi Shafafiya in Abu Dhabi, then compare contracted schedules with Daman, Thiqa where eligible, Sukoon and other payer contracts. The actionable number is the margin after surgeon cost, anaesthesia, consumables, recovery staffing and failed pre-authorisation.

• Eligibility: elective and minimally invasive procedures that do not need an overnight stay.
• Operational test: same-day discharge protocols, escalation pathways and transfer agreements with hospitals.
• Payer test: prior authorisation rules, medical necessity edits and day-case coding accuracy.
• Patient test: location, appointment speed, transparent co-pay and post-discharge contact.

What operators should watch next

For COOs, Burjeel’s structure points to a repeatable operating model: standard clinical pathways, central procurement, workforce planning and clearer unit economics. That is difficult for single-site clinics to match unless they specialise, partner with hospitals or build tighter payer reporting. Medical directors should watch how liability is handled when a patient selected for same-day care needs transfer to a hospital bed.

Patients may benefit if day surgery reduces waiting times and moves care closer to residential catchments. The trade-off is navigation. They still need to verify whether the facility, surgeon, anaesthetist and procedure are covered under their insurance network before admission. Operators should make that verification visible before collection of deposits or consent forms.

The next useful signal will be where Burjeel places its four planned UAE centres. Dubai would put the platform under DHA rules and closer to high-volume insured demand. Abu Dhabi additions would deepen the DOH Abu Dhabi network around Al Reem, Shahama, Al Dhafra and Al Ain. Northern emirates expansion would require MOHAP licensing and a different payer mix.

For a market check on licensed hospitals, clinics and day surgery competitors, readers can use the UAE Open Healthcare Directory to review providers by emirate, specialty and facility type.